20.2 C
Paris
Friday, July 1, 2022
- publicity -

Skinobs preclinical platform celebrates its first anniversary

Publicity

One year after its launch, more than 5,000 users from 80 countries viewed more than 57,000 pages on both clinical and preclinical platforms. The Preclinical platform represents, with more than 1,000 users, 42% of consultations.

Skinobs' platform dedicated to preclinical testing responds to cosmeticians who are looking for screening or proof of concept, mechanisms of action of active ingredients or finished products in-tubo, on cellular models, co-cultures, 3D models of reconstructed or bio-printed skin or explants.

Just like the platform dedicated to clinical trials, this unique tool allows test managers, through reserved and free access, to identify methods and biomarkers, testing laboratories around the world to accelerate your evaluation projects. The platform is updated daily.

Top 10 claims sought: anti-aging, moisturizing, anti-oxidant, microbiota, anti-uv, non-irritating, anti-pollution, anti-inflammatory, strengthens the skin barrier and slimming.

A unique overview of preclinical tests

The platform presents 500 tests, accessible from 125 referenced laboratories, according to 8 preselection categories:

  • Stability and physico-chemical tests
  • Microbiology
  • security
  • Dermal absorption
  • Biodegradability and ecotoxicity
  • Container-content interaction
  • Efficiency
  • UV, UVA, UVB, Infra-red or blue light

"Listening to trends and the evolution of nail, hair and skin technologies, we are working on the continuous improvement of our database. The expectations of geneticists and test providers are at the heart of our thinking and our independent and comprehensive approach," says Anne Charpentier, founder and CEO of Skinobs.

External resources
skinobs.com/preclinical

Related articles

Our latest issue

Listen to us!

Newsletter

We offer you our summer number! Freely access the digital version of Industries CosmétiquesI read !
+
X